Previous studies have shown a pivotal role of the mTOR signalling cascade in primary liver cancer, including CCA, where upon hyper activation, mTOR signalling promotes cell proliferation contributing to tumour progression (Wu et al., 2019; Lu et al., 2021). Here, MTOR is linked to cholangiocarcinoma.